Since its invention, the Camcon Binary Actuation Technology (BAT) has been applied to an array of industry challenges and resulted in major breakthroughs across different markets. But what is its secret?
Below, inventor Wladyslaw Wygnanski – originally an academic from Warsaw Poland; sheds light on its invention and the road to achieving success with his patented BAT and why he believes success can be transferred to healthcare and the life science industries.
Binary Actuation Technology (BAT) was first invented in 1998 by Wladyslaw Wygnanski, who joined forces with Daniel Chapchal and Christopher McDouall († 2017) to apply this precision flow control technology to the oil and gas and automotive industries. Following a decade of huge success, the decision was made to extend the application of BAT into the healthcare and life sciences industries, with the key aim of improving patient outcomes. Thus, Camcon Medical was born. The company have since expanded their executive team to include Charles Potter, who has a depth of knowledge of the medical devices sector, and Simon Saxby, who has a wealth of experience in executive and management positions across the healthcare industry.
Here, Wladyslaw Wygnanski and Charles Potter, both Directors of Camcon Medical Ltd., Daniel Chapchal, Deputy Chairman at Camcon Federation of Companies and Simon Saxby, Advisor to the board at Camcon Medical, provide further insight into their new venture and what they hope to achieve with this versatile and exciting technology.
